Sergio Dompe

Sergio Dompe serves as Chairman and President at Movendo Technology. He also serves as Chairman at Dompe. He is an Angel Investor. Sergio Dompe is President of the namesake biopharmaceutical Group, whose main business involves the development of innovative therapeutic solutions for rare diseases, which often lack any form of treatment. An entrepreneur in the Pharmaceutical and Biotechnology industries, he is awarded an Honorary Doctorate in Biotechnology with specialisation in pharmaceutics (Bologna) in 1996, in Medical Biotechnology (L'Aquila) in 2005 an in Pharmacy (Urbino) in 2010. To date, Dompe has consolidated his efforts in R&D by sponsoring 21 clinical trials involving 1,200 patients worldwide, conducted thanks to partnerships with an international network of 200 research centres.In 2016, Dompe funds and establishes Movendo, an innovative medical company born from an idea of the Italian Institute of Technology to develop the most advanced technologies at the service of man and products in the field of physical movement rehabilitation. In 2016, Sergio Dompe was awarded the Prize of the Foundation Aiuti per la Ricerca sulle Malattie Rare (A.R.M.R.) [Financial Aid to Research on Rare Diseases], an award given to persons who have distinguished themselves for their commitment in research, even as a way of life.